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ABSTRACT
Alterations in cytosine-5 DNA methylation are fre-
quently observed in most types of human cancer.
Although assays utilizing PCR amplification of
bisulfite-converted DNA are widely employed to ana-
lyze these DNA methylation alterations, they are
generally limited in throughput capacity, detection
sensitivity, and or resolution. Digital PCR, in which
a DNA sample is analyzed in distributive fashion
over multiple reaction chambers, allows for enu-
meration of discrete template DNA molecules, as
well as sequestration of non-specific primer anneal-
ing templates into negative chambers, thereby
increasing the signal-to-noise ratio in positive cham-
bers. Here, we have applied digital PCR technology
to bisulfite-converted DNA for single-molecule
high-resolution DNA methylation analysis and for
increased sensitivity DNA methylation detection.
We developed digital bisulfite genomic DNA sequen-
cing to efficiently determine single-basepair DNA
methylation patterns on single-molecule DNA tem-
plateswithoutaninterimcloningstep.Wealsodevel-
oped digital MethyLight, which surpasses traditional
MethyLight in detection sensitivity and quantitative
accuracy for low quantities of DNA. Using digital
MethyLight, we identified single-molecule, cancer-
specific DNA hypermethylation events in the CpG
islands of RUNX3, CLDN5 and FOXE1 present in
plasma samples from breast cancer patients.
INTRODUCTION
Alterations of CpG island DNA hypermethylation and
chromatin modiﬁcation have been widely documented in
human cancers (1,2). DNA methylation changes are not
only detectable in tumors, but also in blood, as tumor-
derived DNA is released into the bloodstream due to
tumor necrosis and apoptosis (3,4). Cancer-speciﬁc
DNA methylation alterations present in cancer tissues
and blood of cancer patients can serve as diagnostic
markers for risk assessment, progression, early detection,
treatment prediction and monitoring (5).
The sensitive detection of speciﬁc DNA methylation
patterns occurring at very low abundance presents
technological challenges that are distinct from the chal-
lenges of determining the sequence of consecutive methyla-
tion states at single base-pair resolution in individual
DNA molecules. The former requires high signal-to-noise
ratio, and generally relies on methylation-speciﬁc PCR
priming (MSP) (6), with optional further enhancement by
methylation-speciﬁc probing (MethyLight) (7), whereas
high-resolution sequencing requires low-sensitivity methy-
lation-independent priming, combined with separation of
PCR products for sequence analysis. This separation has
traditionally been accomplished by a plasmid cloning step
inEscherichiacoli(E.coli)priortosequencing(8).Weshow
here that digital PCR can beneﬁt both DNA methylation
analysis strategies.
Digital PCR (9) was originally described as a tool for the
ampliﬁcation of individual molecules for purposes of iden-
tifying and counting individual DNA molecule sequence
alterations, and now is well-established in determining
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and SNP polymorphisms (10). By distributing a sample
over multiple PCR reaction wells to a mean concentration
well below one template molecule per well, ampliﬁcation of
single template molecules is achieved in a minority of the
wells. This provides a digital readout of the original
number of template molecules in the distributed sample.
We have applied this principle to bisulﬁte genomic sequen-
cing. By omitting the time- and labor-intensive cloning step
in E. coli (8), digital bisulﬁte genomic sequencing greatly
increases the eﬃciency of single-molecule DNA methyla-
tion analysis, and results in a signiﬁcant cost reduction.
PCR wells with positive ampliﬁcation can be recognized
by the use of SYBR Green, and sequencing can be per-
formed directly on the PCR products following clean up.
Thus, digital PCR not only provides information on the
number of discrete templates, but can also be used to sepa-
rate heterogeneous templates into separate ampliﬁcations
for subsequent sequencing. A less well-recognized beneﬁt
of digital PCR is the sequestration of competing back-
ground molecules into negative wells that do not partici-
pate in the PCR ampliﬁcation. As a consequence, the ratio
of template-to-background improves in the positive wells.
Competition for primer annealing by background DNA is
a major problem in the detection of low-abundance meth-
ylation variants by MSP and MethyLight. This problem is
particularly acute for these bisulﬁte-based detection meth-
ods, since sequence redundancy is increased in bisulﬁte-
converted DNA, which contains only three bases outside
of sites of DNA methylation (11).
In this study, we have applied digital PCR technology
to two bisulﬁte-DNA based DNA methylation assays,
digital bisulﬁte genomic DNA sequencing and digital
MethyLight, to obtain DNA methylation information at
high resolution or with high sensitivity, respectively. Both
digital bisulﬁte genomic DNA sequencing and digital
MethyLight are novel, fast, reliable and cost eﬀective mea-
sures for determining DNA methylation information of
individual DNA molecules, and are easily customizable
to the analysis of any gene region and sample type.
MATERIALS AND METHODS
M.SssI andwhole genome amplification treatments
Human peripheral blood leukocyte (PBL) DNA was pur-
chased from Promega Corporation (Madison, WI) and
75mg DNA was treated with 75 units M.SssI methylase
(New England Biolabs, Ipswich, MA) together with
0.16mM S-adenosylmethionine (SAM) at 378C for 16h.
Additional SAM and 25 units of M.SssI methylase were
added and incubated overnight at 378C. The enzyme was
inactivated and directly used for bisulﬁte conversion. The
M.SssI-DNA sample serves as a positive control for DNA
methylation in bisulﬁte sequencing and MethyLight
assays. Multiple M.SssI treatments are beneﬁcial for com-
pletely methylating a DNA sample.
We used whole genome ampliﬁcation (WGA) to gener-
ate unmethylated DNA for methylation analyses. In brief,
5ng genomic PBL DNA was used as input for ampliﬁca-
tion. WGA-DNA was puriﬁed by phenol-chloroform
extraction, precipitated with ethanol, and re-suspended
in 50ml water. We recovered 10 20mg WGA-DNA after
puriﬁcation. The WGA sample essentially contains back-
ground levels of DNA methylation, with less than 0.1%
of methylated cytosines remaining in the WGA-DNA
sample. Whole genome ampliﬁcation using the REPLi-G
kit (Sigma, Valencia, CA) was performed as described by
the manufacturer.
Bisulfite conversion and recovery
DNA samples (1mg genomic DNA for each) were treated
with bisulﬁte as previously described (11). The puriﬁed
bisulﬁte-converted samples were eluted in 120ml volume,
and in order to remove traces of ethanol-based PCR
inhibitors, we then incubated the samples at 808C for
20min, and then stored the samples at –308C until needed.
Digital bisulfite genomic DNA sequencing
Fresh-frozen tumor DNA (1mg) from two colorectal
cancer patients (Laird IDs 6317 and 6363) was bisulﬁte
converted and recovered as described above. For the
conventional, cloning-based bisulﬁte DNA sequencing
approach, we ampliﬁed a portion of the MLH1 CpG
island using forward and reverse primers listed in
Table 1. The PCR was performed on a Robocycler
(Stratagene, La Jolla, CA) containing 200mM dNTPs,
2mM MgCl2, 0.3mM forward and reverse primers and
0.5 units of Taq polymerase (Invitrogen, Carlsbad, CA).
The PCR conditions are as follows: 958C for 3min, then 35
cycles of 958C for 1min, 558C for 1min and 728C for one
min. A ﬁnal incubation at 728C for 15min concluded the
PCR. PCR products were veriﬁed by gel electrophoresis,
and a small aliquot of the PCR reaction was used with the
TOPO-TA cloning system (Invitrogen) as suggested by the
manufacturer. Clones were picked from LB-Amp cultures,
and then were screened and ampliﬁed using M13 primers.
Positive clones were then sequenced using the following
sequencing primer: 50-GGT ATT TAA GTT GTT TAA
TTA ATA GTT GT -30 by the USC/Norris Cancer Center
DNA Sequencing Core Facility.
For the digital bisulﬁte genomic DNA sequencing
assay, we ﬁrst established the amount of bisulﬁte con-
verted DNA to load on the 96-well PCR assay in order
to avoid over- or under-loading the template DNA. To
accomplish this, we determined the relative amounts of
each sample through the use of a TaqMan PCR reaction
(C-LESS-C1), which recognizes a DNA strand that does
not contain cytosines, and hence will be able to amplify
the total amount of DNA (bisulﬁte-converted or uncon-
verted) in a PCR reaction well. The C-LESS forward
sequence is provided in Table 1 and was purchased from
Applied Biosystems. An unconverted DNA sample of
known concentration was serially diluted and used as a
standard curve. Since the C-LESS reaction ampliﬁes both
template strands of unconverted genomic DNA but only
one strand of bisulﬁte-converted DNA, we expect that
bisulﬁte-converted DNA will amplify one PCR cycle
later than that of unconverted DNA. To correct for this,
we multiplied the amount of bisulﬁte-converted DNA for
each sample quantitated from the C-LESS standard curve
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bisulﬁte-converted DNA for use in digital bisulﬁte sequen-
cing assays.
We next performed digital PCR for the MLH1 locus
using bisulﬁte-speciﬁc forward and reverse primers
(described in Table 1). For each assay, we generated PCR
products from 15 20 molecules after loading 300 400pg
of bisulﬁte-converted DNA in each PCR plate. Assuming
each haploid genome contains 3.3pg DNA, we loaded
90 120 copies of bisulﬁte-converted DNA into each
96-well plate. In comparing the number of ampliﬁed
DNA molecules to the estimate of genome equivalents
loaded into the assay, we found an approximate 15 20%
sensitivity of amplifying individual MLH1 DNA molecules
using digital bisulﬁte genomic DNA sequencing. In order
to minimize the occurrence of two or more PCR templates
in a single well, we limited each assay to a maximum of
20 30 ampliﬁable molecules per PCR plate.
Each PCR reaction used the iQ SYBR Green Supermix
(Bio-Rad, Hercules, CA) and 0.3mM forward and reverse
primers in a 1.44ml total volume. This volume was dis-
persed in 15ml aliquots over an entire 96-well plate, and
the PCR was performed using an Opticon real-time ther-
mal cycler (Bio-Rad) using the PCR program of 958C for
10min, followed by 50 cycles of 958C for 15s and 558C for
1min. Using a melting curve analysis, we identiﬁed the
melting curve of the PCR product in each well. Primer
dimers melted at approximately 708C, while PCR prod-
ucts derived from single template DNA molecules melted
between 77 858C.
We randomly chose true PCR products for sequencing.
We removed 10ml from each well, and removed unused
dNTPs and primers using the ExoSAP-IT kit (USB
Corporation, Cleveland, Ohio) according to the manufac-
turer’s speciﬁcations. The MLH1 sequencing primer was
added to each treated sample, and each sample was subse-
quently sequenced by the USC/Norris Comprehensive
Cancer Center DNA Sequencing Core Facility. Interest-
ingly, we noticed that the PCR products with high melting
temperatures as reported by the melting curve analyses
were CpG-methylation rich, while the PCR products with
lower melting temperatures were generally unmethylated.
Weusedthiscorrelationasaqualitycontrolafterobtaining
the bisulﬁte sequencing information of each single-
molecule derived PCR product.
DigitalMethyLight evaluation experiments
Each MethyLight reaction used in this report has been
thoroughly and extensively evaluated for speciﬁcity to
methylated DNA only. We routinely evaluate each
MethyLight reaction on white blood cell DNA: M.SssI
treatment, bisulﬁte conversion and whole genome
ampliﬁcation. All MethyLight reactions used were positive
in M.SssI-treated, bisulﬁte-converted DNA and negative in
sampleswithoutM.SssI-treatment,withoutbisulﬁteconver-
sion and with whole genome ampliﬁcation. In addition, we
have also tested each digital MethyLight assay for the pres-
ence of any false-positive signals in 20 PCR plates that do
not contain template DNA. We failed to detect any ampli-
ﬁcation signals on any of these assays. Therefore, we feel
conﬁdent that the signals we detect in this report are indeed
ampliﬁcations of single methylated DNA molecules.
Each bisulﬁte-converted DNA sample was mixed with
200mM dNTPs, 0.3mM forward and reverse PCR primers,
0.1mM probe, 3.5mM MgCl2, 0.01% Tween-20, 0.05%
gelatin and 50 units of Taq polymerase (Applied Biosys-
tems, Foster City, CA) in a 2.85ml total volume. The
PITX2 MethyLight primers and probe were obtained
from BioSearch Technologies and are listed in Table 1.
The entire reaction mixture was aliquotted over a 96-well
plate at 30ml per PCR reaction well, and the PCR program
used was 958C for 10min, followed by 50 cycles of 958C for
15s then 608C for 1min. The number of methylated DNA
molecules was scored as the number of quality real-time
PCR ﬂuorescence curves over the entire PCR plate.
For the M.SssI-DNA dilution series (Figure 3B),
bisulﬁte-converted, M.SssI-DNA was diluted in serial
1:3 dilutions, and the MethyLight PCR reaction mixture
was the same as above, except we used 16.67 units of Taq
polymerase in a 0.96ml total volume, which was distrib-
uted in 10ml aliquots over 96 reaction wells. We used
184ng of bisulﬁte-converted DNA for the most concen-
trated M.SssI-treated DNA sample and 3-fold dilutions of
that sample in the remaining dilutions. The digital
MethyLight PCR reactions were performed as above.
The reactions were analyzed on an Opticon DNA
Table 1. PCR primer and probe DNA sequences
Reaction ID HB-number Forward primer
sequence (50 to 30)
Reverse primer
sequence (50 to 30)
Probe sequence
(50 to 30)
MLH1-C2 HB-665 GAT TGG TAT TTA AGT
TGT TTA ATT AAT AG
CAA TCA TCT CTT TAA
TAA CAT TAA CTA A
PITX2-M2 HB-235 AGT TCG GTT GCG CGG TT TAC TTC CCT CCC CTA
CCT CGT T
6FAM-CGA CGC TCG CCC
GAA CGC TA-BHQ-1
a
C-LESS-C1 HB-344 TTG TAT GTA TGT GAG
TGT GGG AGA GA
TTT CTT CCA CCC CTT
CTC TTC C
6FAM-CTC CCC CTC TAA
CTC TAT-MGBNFQ
b
FOXE1-M1 HB-417 GGG TTA GTT CGC
GAC GAT TTT
CGA ACC TAA CGT CCC CGA 6FAM-CGA ACG CTC GAC
CCT TCT ACG AAA AAC T-BHQ-1
CLDN5-M1 HB-415 TGA GGG CGC GGG ATC CCT AAA CCA ACC CAA
AAT ACG CT
6FAM-CGA CCG CGA CTA
AAA CAA CGA CGA ATA A-BHQ-1
aBHQ-1 refers to a Black Hole Quencher at the 30 terminus of the probe.
bMGBNFQ refers to a Minor Groove Binder non-ﬂuorescent quencher in the 30 terminus of the probe.
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the number of positive ampliﬁcations for each sample was
scored.
The approximate number of bisulﬁte-converted DNA
molecules in the most concentrated M.SssI-DNA sample
was determined using the C-LESS-C1 reaction. An uncon-
verted DNA sample of known concentration was serially
diluted and used as a standard curve, and the DNA con-
centration in the M.SssI-DNA sample was then deter-
mined in a similar manner to the digital bisulﬁte
sequencing protocol. Since the C-LESS ampliﬁcation of
bisulﬁte-converted DNA will be delayed by one cycle com-
pared to unconverted DNA, we multiplied this concentra-
tion by the PCR eﬃciency (1.83 in this experiment) of the
C-LESS reaction as a correction factor. With this ﬁnal
concentration value, we determined the number of molec-
ules present in the assayed DNA sample volume, and then
extrapolated the number of DNA molecules for the
remaining M.SssI-DNA dilution series. Based on these
calculations, we detected approximately 25% of the avail-
able methylated PITX2 DNA molecules in the digital
MethyLight assay.
Comparison ofdigital andclassic MethyLight assay
sensitivities
M.SssI-DNA and WGA-DNA samples (1mg each) were
individually treated with bisulﬁte as described above.
A mixture of 25pg bisulﬁte-converted M.SssI-DNA and
50ng of bisulﬁte-converted WGA-DNA was analyzed for
PITX2 methylation with the mixture analyzed in one well
(classic MethyLight assay) and the remaining 95 wells of a
PCR plate (digital MethyLight assay). The Classic Methy-
Light assay was performed by incubating the bisulﬁte-
converted M.SssI- and WGA-DNA samples in one PCR
reaction well with 200mM dNTPs, 0.3mM forward and
reverse PCR primers, 0.1mM probe, 3.5mM MgCl2,
0.01% Tween-20, 0.05% gelatin and 0.5 units of Taq poly-
merase in a 30ml reaction volume. For the digital
MethyLight assay, the bisulﬁte-converted M.SssI- and
WGA-DNA samples were mixed with 200mM dNTPs,
0.3mM forward and reverse PCR primers, 0.1mM probe,
3.5mM MgCl2, 0.01% Tween-20, 0.05% gelatin and 50
units of Taq polymerase in a 2.85ml total volume. This
reaction mixture was aliquotted over 95 PCR reaction
wells with 30ml per well. This comparison was analyzed
20 times for each assay.
Analysisof DNA methylation in plasma using digital
MethyLight
Plasma from breast cancer patients and controls was
obtained from the University of Texas M.D. Anderson
Cancer Center (Houston, TX). DNA was puriﬁed from
500ml plasma using the Qiagen Blood DNA kit (Qiagen,
Valencia, CA) and converted with bisulﬁte using the Zymo
EZ DNA methylation kit (Zymo, Orange, CA) according
to manufacturer’s speciﬁcations. For each sample, an
amount of bisulﬁte-converted DNA equivalent to 100ml
of plasma was mixed with MethyLight reactions speciﬁc
for RUNX3 (RUNX3-M1, HB-181), FOXE1 (FOXE1-
M1, HB-417) or CLDN5 (CLDN5-M1, HB-415). These
MethyLight primers and probes were obtained from
Biosearch Technologies. Each digital MethyLight reaction
was prepared with 200mM dNTPs, 0.3mM forward and
reverse PCR primers, 0.1mM probe, 3.5mM MgCl2,
0.01% Tween-20, 0.05% gelatin and 50 units of Taq poly-
merase in a 2.85ml total volume. This volume was dis-
persed in 30ml aliquots over an entire 96-well PCR
reaction plate. For the multiplexed digital MethyLight
assay, an amount of bisulﬁte-converted DNA present in
100ml of each plasma sample was prepared the same as
above, except each MethyLight reaction was present at a
concentration of 0.1mM forward and reverse PCR primers
and 0.1mM probe. Each digital MethyLight assay was
performed on an Opticon Real-time PCR system, and
the PCR program is 958C for 10min, followed by 50
cycles of 958C for 15s then 608C for 1min. The number
of methylated DNA molecules was scored as the number
of quality real-time PCR ﬂuorescence curves over the
entire PCR plate. The MethyLight primers for RUNX3-
M1 have been previously described (12). The MethyLight
primers probe sequences for CLDN5-M1 and FOXE1-M1
are listed in Table 1.
Microfluidic digital MethyLight
Bisulﬁte-converted M.SssI-treated DNA (1mg) in a 110ml
volume was concentrated to a ﬁnal volume of 30mlb y
speed-vac evaporation. This sample was then serially
diluted 1:5 and 3.76ml of each dilution was used for micro-
ﬂuidic digital MethyLight analysis. We determined the
amountofbisulﬁte-convertedDNAfromtheC-LESSreac-
tion as described above. We loaded 19.20ng, 3.84ng,
0.77ng, 0.15ng and 0.03ng of bisulﬁte-converted DNA
into separate channels of the microﬂuidic array. A master-
mix for the PITX2 MethyLight assay was prepared in a
8.24ml total volume consisting of 200mM dNTPs, 0.3mM
forward and reverse PCR primers, 0.1mM probe, 3.5mM
MgCl2, 0.05% Tween-20, 0.05% gelatin, 0.5 units of Taq
polymerase. The 11ml total reaction volume for each serial
dilution was loaded onto a Fluidigm BioMark Digital
Array according to manufacturer’s speciﬁcations. Each
reaction was subdivided into 1104 chambers, such that
each chamber contained a 10 nl PCR reaction. The PCR
program is the same as with the 96-well based digital
MethyLight assay for 50 cycles. PCR products were visua-
lized by ﬂuorescence emission and detection by a CCD
camera contained within the BioMark platform. Images
were taken at nearly every cycle throughout the PCR pro-
gram, and screening the TaqMan ﬂuorescence curves for
each chamber via BioMark software eliminated false
positives.
RESULTS
Digital bisulfite genomic DNA sequencing
The human genome contains an abundance of DNA
methylation information, and cancer-speciﬁc methylated
DNA sequences are a powerful biomarker of disease,
tumor recurrence and clinical outcome. Obtaining high-
resolution continuous DNA methylation information for
longer stretches of DNA is possible via bisulﬁte genomic
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and time ineﬃcient with the required subcloning steps in
order to isolate individual DNA molecules. Since digital
PCR was shown to compartmentalize the individual tem-
plate DNA molecules into separate PCR reaction wells,
we applied this technology to bisulﬁte DNA sequencing
with the hopes of quickly amplifying bisulﬁte-converted
DNA of a speciﬁc locus for the purposes of obtaining
high resolution DNA methylation sequence information.
Our approach, as described in Figure 1, was to com-
partmentalize and amplify individual bisulﬁte-converted
DNA molecules in a 96-well PCR reaction plate with pri-
mers speciﬁc for bisulﬁte-converted DNA. PCR products
derived from single template DNA molecules are then
identiﬁed, puriﬁed and sequenced directly without a sub-
cloning step. To test this, we designed a PCR reaction
speciﬁc for bisulﬁte-converted DNA sequence within the
MLH1 CpG island (MLH1-C2) that can be used to com-
pare both the conventional and digital bisulﬁte sequencing
assays. The MLH1-C2 PCR primers are speciﬁc for
bisulﬁte-converted DNA but are methylation-indepen-
dent, such that all possible DNA methylation patterns
can be ampliﬁed prior to sequencing. Fresh-frozen
tumor DNA samples from two colorectal cancer patients
were used, both shown to harbor MLH1 DNA methyla-
tion by MethyLight analysis (12). Using the conventional
bisulﬁte DNA sequencing approach ﬁrst, we PCR ampli-
ﬁed the MLH1 locus for each bisulﬁte-converted sample,
and then ligated each PCR product into a TOPO-TA
vector. These were subsequently transformed into E. coli
and subclones composed of individual DNA molecules
were isolated and sequenced. One DNA sample (6363)
showed extensive methylation of the MLH1 CpG island,
while individual clones of the other DNA sample (6317)
showed fewer methylated CpG dinucleotides (Figure 2A).
We next performed digital PCR on the bisulﬁte-
converted DNA samples using the same MLH1-C2 pri-
mers. In order to minimize the occurrence of two or
more PCR templates in a single well, we targeted a max-
imum of 20 30 molecules per PCR plate. After PCR,
wells containing valid ampliﬁed products were identiﬁed
using a SYBR green melting curve analysis. An aliquot of
the PCR reaction containing ampliﬁed DNA from single
molecules was then puriﬁed using Exonuclease I and
Shrimp Alkaline Phosphatase (Exo-SAP-IT) to remove
primer and dNTPs, and was then subjected to DNA
sequencing. The individual bisulﬁte-converted DNA mole-
cules showed an MLH1 DNA methylation proﬁle com-
parable to those derived from TOPO-TA cloning-based
DNA sequencing for each sample (Figure 2B). However,
we did detect two instances in which both methylated and
unmethylated signals for the same CpG (highlighted by
the asterisk) were observed, suggesting that this may be
the result of two DNA molecules present in one PCR
reaction well prior to ampliﬁcation or an error in the
DNA sequence analysis for this CpG dinucleotide.
Digital MethyLight
DNA methylation alterations are abundant in human can-
cers, and one approach to early detection of cancer has
Figure 1. Digital bisulﬁte genomic DNA sequencing overview. An
amount of bisulﬁte-converted DNA was loaded such that individual
template DNA molecules were ampliﬁed on a 96-well PCR plate. We
targeted a maximum of 20 30 molecules to be sequenced in each PCR
plate in order to minimize the occurrence of two or more PCR template
molecules per reaction well. Positive ampliﬁcations are evaluated by
SYBR green melting curve analyses, and PCR products from these
wells are removed and puriﬁed with Exonuclease I and Shrimp
Alkaline Phosphatase (Exo-SAP-IT) to remove unused PCR primers
and dNTPs. PCR products representing individual DNA molecules
are then subject to DNA sequencing.
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patient blood. However, this strategy has been hampered
by relatively low sensitivity (5). This low sensitivity stems
in part from the low absolute concentration of circulating
tumor-derived DNA in some patients, combined with a
large excess of PCR inhibitory contaminants and compet-
ing background DNA. Digital PCR was developed as a
compartmentalized PCR reaction to allow for detection
and counting of discrete template molecules (9). We the-
orized that digital PCR technology would have an addi-
tional beneﬁt of sequestering background DNA and
contaminants into wells that do not contain ampliﬁable
templates, thereby increasing the signal-to-noise ratio
of the positive wells. We tested this concept in a new
application, termed digital MethyLight, which utilizes
MethyLight to interrogate a bisulﬁte-converted DNA
sample distributed over multiple independent chambers.
In the ﬁrst implementation, we tested this principle in a
96-well plate format (Figure 3A).
We applied digital MethyLight to serial dilutions of
M.SssI-treated DNA using a MethyLight reaction for
methylated PITX2 (Figure 3B). As the sample is diluted,
the cycle threshold (Ct) values increase. However, as the
number of available templates becomes limiting, the assay
transitions from a quantitative measurement to a dichot-
omous measurement of stochastically distributed indi-
vidual molecules. At this point, the mean Ct value no
longer increases with further dilution, as one would
expect for the detection of a single, discrete molecule, as
demonstrated for digital bisulﬁte genomic sequencing. For
PITX2, this occurs at approximately cycle 40 (Figure 3B).
We used a TaqMan PCR reaction (C-LESS-C1), which
is derived from a unique DNA sequence near the
SLC24A3 gene that does not contain cytosines on one
DNA strand to determine DNA quantities. This reaction
can detect unconverted as well as bisulﬁte-converted DNA,
and hence will be able to quantitatively measure the total
amount of DNA independent of bisulﬁte-conversion. In
comparing the number of methylated PITX2 DNA mole-
cules to the estimate of genome equivalents in the reaction
(Figure 1B), we found an approximate 25% sensitivity of
detecting and amplifying individual methylated PITX2
DNA molecules using digital MethyLight (Figure 3B).
We compared the sensitivity of digital MethyLight and
classic MethyLight assays under challenging conditions
of a large excess of unmethylated DNA. We mixed 25pg
of M.SssI-treated, bisulﬁte-converted DNA (equivalent of
approximately three to four cells) with a 2000-fold molar
excess of genomic DNA devoid of DNA methylation by
whole genome ampliﬁcation. This mixture was analyzed 20
times for PITX2 methylation, by both classic and digital
MethyLight assays on 96-well PCR reaction plates, with
one PCR reaction well of each plate dedicated to the
Classic MethyLight assay and all remaining 95 wells of
each plate constituting a single digital MethyLight assay
(Figure 3C). By using mixtures of 25pg M.SssI-DNA
(methylated DNA)+50ng WGA-DNA (unmethylated
DNA) in each assay, both classic and digital MethyLight
assays interrogated equal quantities of methylated and
unmethylated DNA, and therefore accurately compared
assay sensitivities. Only 4 of the 20 classic assays (20%)
detected PITX2 methylation. However, 17 of 20 digital
MethyLight assays (85%) were able to detect PITX2
methylation, with many digital assays detecting multiple
methylated PITX2 loci, suggesting that digital MethyLight
can detect methylated DNA molecules with an increased
sensitivitycomparedtoclassicMethyLight.Wedetermined
that digital MethyLight technology was a statistically sig-
niﬁcant improvement over classic MethyLight through the
use of a paired two-tailed t-test (P<0.0001).
Microfluidic digital MethyLight
Even though digital MethyLight can detect single meth-
ylated DNA molecules, each 96-well assay is reagent inten-
sive. Therefore, we tested digital MethyLight for its ability
Figure 2. Comparison between conventional and digital bisulﬁte geno-
mic DNA sequencing of MLH1 CpG island. Bisulﬁte-converted tumor
DNA from two colorectal cancer patients was ampliﬁed at the MLH1
locus and subject to (A) TOPO-TA cloning followed by DNA sequen-
cing, and (B) Digital bisulﬁte genomic DNA sequencing. Each horizon-
tal line represents an individual DNA molecule, and the circles
represent CpG dinucleotides. Filled in circles are methylated CpGs
while open circles are unmethylated CpGs. The asterisk ( ) represents
DNA sequencing reads that gave signals for both methylation and the
absence of methylation for a speciﬁc CpG dinucleotide, and may be
indicative of two DNA molecules ampliﬁed in the PCR reaction well.
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Fluidigm microﬂuidic platform (13,14) in which 12 DNA
samplescanbeassayedsimultaneously.EachPCRreaction
is compartmentalized into 1104 individual 10 nl reaction
chambers, enabling the detection of single methylated
DNA molecules in an 11ml total reaction volume.
Individually ampliﬁed methylated DNA molecules were
then visualized via the MethyLight probe ﬂuorescence
signals using a high-resolution CCD camera. We applied
microﬂuidic MethyLight technology to serial dilutions
of M.SssI-treated DNA (Figure 4). Using the microﬂuidic
platform, we were also able to amplify single methylated
PITX2 molecules. This high-throughput digital
MethyLight approach can successfully and sensitively
Figure 3. Digital MethyLight-based real-time PCR ampliﬁcation. (A) Principle of amplifying individual methylated DNA molecules using digital
MethyLight. A bisulﬁte-converted DNA sample is diluted and divided into multiple PCR reaction wells such that the target methylated DNA molecules
are less than one molecule per reaction well. (B) Digital MethyLight was applied to serial dilutions of in vitro methylated DNA. The PITX2 MethyLight
reaction for each serial dilution was spread over 96 PCR reaction wells, the ﬂuorescence signals for each dilution were plotted against the PCR cycle
number and the number of positives were counted. The approximate number of haploid genomes was also evaluated for each dilution. The dashed vertical
line represents the mean cycle threshold (Ct) value of single methylated PITX2 DNA molecules. (C) Comparison of digital and classic MethyLight assay
sensitivities. Two identical mixtures of 25pg M.SssI-DNA plus 50ng of unmethylated WGA-DNA were each analyzed for PITX2 methylation with one
mixture analyzed in one well (classic) and the second analyzed over the remaining 95 wells of a PCR plate (digital). This experiment was analyzed 20 times
for each assay. The positive methylated PITX2 molecules are indicated by the black wells and the + symbol indicates a positive signal for each assay. The
percentage of assays positive for PITX2 methylation is plotted for both classic and digital MethyLight assays.
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PCR reaction volumes.
DetectionofmethylatedDNAinbreastcancerpatientplasma
using digital MethyLight
We tested the digital MethyLight technology on biological
samples for the detection of tumor-derived, methylated
DNA in the bloodstream. We applied digital
MethyLight to DNA isolated from plasma of 44 breast
cancer patients of diﬀerent stages of disease and 13 appar-
ently normal individuals. MethyLight reactions speciﬁc
for methylated CpG islands located in the promoter
regions of FOXE1, CLDN5 and RUNX3 were selected
for this analysis. Using classic MethyLight, these reactions
showed high cancer speciﬁcity in breast cancer tumor sam-
ples, and did not detect methylation in a test panel of
plasma and white blood cells (WBC) from age-matched
healthy control individuals (data not shown). As a result,
these reactions would generate a low background signal
from lysed WBCs and other free DNAs present in the
breast cancer patient plasma samples.
We tested each of the three MethyLight reactions sepa-
rately on bisulﬁte-converted DNA isolated from 100ml
plasma using digital MethyLight, and we detected meth-
ylated DNA molecules in one stage II and several stage IV
breast cancer patients, with the most abundant methyla-
tion seen in Stage IV patients (Figure 5). Methylated
FOXE1 and RUNX3 molecules were more abundant
than methylated CLDN5 DNA, especially in the stage
IV cases. To increase the sensitivity of methylated DNA
detection, we multiplexed all three MethyLight reactions
into one assay for each plasma sample. As expected, we
detected an approximately cumulative number of DNA
hypermethylation events using the multiplexed assay,
thereby increasing sensitivity. One of the stage IV cases
with background methylation levels of the individual mar-
kers became more evident after multiplexing, rising
slightly above background levels (Figure 5). We found
that although there were plasma samples with substantial
amounts of free DNA, this did not correlate with the
number of methylated DNA molecules in patient or con-
trol plasma based on an assessment of DNA quantities
using a TaqMan PCR reaction speciﬁc for ALU repeats
(Figure 5). We conclude that the careful selection of
MethyLight reactions eﬀectively avoids detecting DNA
methylation from lysed white blood cells or background
DNA methylation in plasma.
DISCUSSION
In this study, we have developed two novel DNA meth-
ylation analysis tools utilizing digital PCR technology.
Digital MethyLight allows for detection of individually
methylated DNA molecules in a large background of
Figure 5. Digital MethyLight on plasma samples from 44 breast cancer
patients and 13 apparently healthy controls. DNA from 500ml plasma
was puriﬁed, bisulﬁte converted and a DNA amount from 100ml
plasma was subject to digital MethyLight. Each sample was analyzed
individually for FOXE1, CLDN5 or RUNX3 methylation, as well as
with all three reactions multiplexed. The results are presented as the
number of methylated molecules per 100ml plasma for each sample.
The DNA concentration in each plasma sample was estimated based
on a TaqMan reaction speciﬁc for ALU repetitive elements.
Figure 4. Detection of single methylated PITX2 molecules serial dilu-
tions of bisulﬁte-converted M.SssI-DNA using microﬂuidic digital
MethyLight (Fluidigm). Each DNA sample was compartmentalized
into 1104 reaction chambers of 10nl each and ampliﬁcations were
visualized by ﬂuorescence emission in each positive chamber.
4696 Nucleic Acids Research, 2008, Vol. 36, No. 14unmethylated DNA, while digital bisulﬁte genomic DNA
sequencing generates high-resolution DNA methylation
information without the need for a subcloning step.
Both assays are eﬃcient and eﬀective methods of obtain-
ing DNA methylation information for samples with small
amounts of DNA. Single-molecule analysis is possible by
compartmentalizing the template across multiple PCR
reaction wells. Not only are single molecules isolated,
the background and other PCR contaminants are also
diluted, and the ratio of primer to methylated template
DNA is kept high.
Digital MethyLight was shown to be more sensitive than
classic MethyLight in detecting a small number of meth-
ylated molecules in a large background of unmethylated
DNA. Digital MethyLight, in compartmentalizing the
methylated DNA molecules over multiple PCR wells, also
reduces the background and contaminant levels, thereby
reducing their PCR inhibitory eﬀects and increasing meth-
ylated DNA detection sensitivity. This strategy allowed us
to detect and quantify the number of individual methylated
DNAmoleculesinplasmasamplesofbreastcancerpatients.
Digital MethyLight is the most sensitive assay described to
date for detecting methylated DNA in biological ﬂuids.
The additional reﬁnement of multiplexing digital
MethyLight assays increased the sensitivity of detecting
methylated DNA loci in plasma samples. Although the
multiplexed assays detected DNA hypermethylation
mostly in plasma from Stage IV breast cancer patients,
we did detect DNA methylation in one stage II patient.
This emphasizes the need to further improve the detection
sensitivity so that earlier stages of disease can be detected.
This may be achieved by using an increased number
of multiplexed MethyLight markers in each digital
MethyLight assay. Nonetheless, the CpG islands located
in RUNX3, FOXE1, and CLDN5 are promising DNA
methylation markers for breast cancer patients. RUNX3
DNA methylation was previously shown in breast cancer
patients (15), while FOXE1 and CLDN5 methylation in
breast cancer has not been described previously.
We used an amount of DNA present in a small volume
(100ml)ofserumfordigital MethyLight-based detection.A
recent study (16) identiﬁed DNA methylation of SEPT9 in
69% of colorectal cancer plasma samples from measure-
ments of milliliter volumes of patient plasma. While the
amount of cancer patient plasma or serum is usually limit-
ing for laboratory use, larger volumes of plasma or serum
in digital MethyLight assays may increase the detection
sensitivity of individual methylated DNA molecules.
Nonetheless, the early detection of methylated DNA in
biological ﬂuids using digital MethyLight has great prom-
ise in cancer detection and surveillance.
We also described digital bisulﬁte DNA sequencing as
a powerful method of amplifying individual bisulﬁte-
converted DNA molecules for DNA sequencing. DNA
methylation patterns of individual gene loci can be
heterogeneous and an understanding of the DNA methy-
lation patterns of individual molecules may be helpful to
determine the role of DNA methylation in gene regulation
and the mechanism of DNA methylation at speciﬁc gene
loci. Digital bisulﬁte genomic DNA sequencing is a quick
and eﬃcient assay in which individual template DNA
molecules can be ampliﬁed, screened, puriﬁed and
sequenced in the same day. This assay is time and labor
eﬀective in comparison to subcloning techniques to isolate
individual bisulﬁte-converted DNA molecules.
Two recent reports also highlight the application of
digital PCR to bisulﬁte-converted DNA. Chhibber and
Schroeder (17) performed DNA sequencing after serial
dilution of bisulﬁte-converted template DNA and
showed that single-molecule PCR eliminated PCR and
cloning biases. Snell and colleagues (18) reported the use
of digital methylation-sensitive high-resolution melting
(HS-HRM), followed by bisulﬁte genomic sequencing, to
measure DNA methylation of the BRCA1 promoter CpG
island in breast cancer patients. Our digital bisulﬁte
genomic DNA sequencing protocol also reduces PCR
bias, circumvents cloning strategies and increases the
signal-to-noise in detecting and amplifying individual
methylated DNA molecules. We correlated melting tem-
perature diﬀerences with diﬀerences in DNA methylation
proﬁles of PCR products, as methylated bisulﬁte-con-
verted DNA is more G:C rich and therefore melts at a
higher temperature than unmethylated DNA.
A study from Taylor et al. (19) used 454 next-generation
sequencingtechnologytoidentifyindividualmoleculeCpG
methylation patterns in lymphoma and leukemia primary
cells. While this assay is robust and powerful in generating
large amounts of bisulﬁte sequencing data, there are sub-
stantial equipment and informatics requirements for 454
and other next-generation DNA sequencing platforms.
Although digital bisulﬁte genomic DNA sequencing does
not generate the amount of sequence data compared to 454
Sequencing, only a real-time PCR machine is required and
approximately 20 30 individual molecules can be quickly
assayed andsequenced. High-resolution sequence informa-
tion of 20 30 DNA molecules can provide a detailed
understanding of DNA methylation events at candidate
gene loci. Digital bisulﬁte genomic DNA sequencing is an
advantageous and ﬂexible technology for determining
single-molecule DNA methylation patterns of a wide
range of DNA samples and gene loci.
In conclusion, the work presented here describes novel
advancements in single-molecule DNA methylation detec-
tion and bisulﬁte sequencing. Digital MethyLight and
digital bisulﬁte genomic DNA sequencing are cost and
time eﬀective methods in which a wide range of samples
and loci can be assayed.
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